Crédit Agricole Corporate and Investment Bank, Sucursal en España

Crédit Agricole Corporate and Investment Bank, Sucursal en España is the Spanish branch of Crédit Agricole CIB, the corporate and investment banking arm of the Crédit Agricole Group, operating in Spain as a wholesale institution focused on professional clients rather than retail customers. The branch provides financing and advisory services to large corporates, financial sponsors, financial institutions, and public-sector entities, covering areas such as syndicated and bilateral lending, leveraged and acquisition finance, project and infrastructure finance, real assets and export/ECAs-backed finance, trade and commodity finance, and structured credit and securitization; it also arranges and places debt capital markets instruments, including investment-grade, high-yield, private placements, and covered or asset-backed formats, and offers equity-linked or hybrid solutions where applicable. Markets activity typically includes rates, FX and credit derivatives for hedging, commodities risk management, and securities financing, supported by standard market documentation (e.g., LMA for loans, ISDA/CSA and GMRA/OSLA for derivatives and repos); advisory mandates may cover capital structure, liability management, and selected M&A transactions alongside sector coverage teams. The branch participates in sustainability-linked financing and labelled bond structuring in line with EU market standards and disclosure frameworks. As an EU bank branch, it is subject to prudential supervision within the Single Supervisory Mechanism (ECB in cooperation with the French ACPR as home authority) and to host-country conduct and market oversight by Spanish regulators for activities performed in Spain, including Banco de España and the CNMV for investment services; applicable regimes include CRR/CRD, MiFID II, EMIR, MAR, sanctions and AML/KYC rules, and GDPR. It does not market consumer deposits or payment accounts in Spain, onboarding is geared to institutional and large corporate requirements, pricing is negotiated on a transaction-by-transaction basis, and product availability is dependent on internal risk appetite, market conditions, and regulatory constraints; prospective mandates typically involve sizeable minimum ticket sizes and detailed due diligence, with execution timelines influenced by documentation complexity and approvals.